{
  "paper_metadata": {
    "pmid": "35464868",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7934del",
      "protein_notation": null,
      "genomic_position": "rs80359688",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Caucasian, Afrikaner",
        "phenotype": "breast and/or ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The Afrikaner founder variant BRCA2 c.7934del (rs80359688) was the most common."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a predisposition to breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is a founder mutation in the Afrikaner population.",
      "key_quotes": [
        "The Afrikaner founder variant BRCA2 c.7934del (rs80359688) was the most common."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5771_5774del",
      "protein_notation": null,
      "genomic_position": "rs80359535",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Black African",
        "phenotype": "breast and/or ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The Black African founder variant BRCA2 c.5771_5774del (rs80359535) was identified."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a predisposition to breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is a founder mutation in the Black African population.",
      "key_quotes": [
        "These include BRCA2 c.5771_5774del (legacy name 5999del4) and BRCA2 c.582G>A, both Black African founder mutations."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.582G>A",
      "protein_notation": null,
      "genomic_position": "rs80358810",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Black African",
        "phenotype": "breast and/or ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "BRCA2 c.582G>A [rs80358810] (Oosthuizen et al., 2021)."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a predisposition to breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is a founder mutation in the Black African population.",
      "key_quotes": [
        "These include BRCA2 c.5771_5774del (legacy name 5999del4) and BRCA2 c.582G>A, both Black African founder mutations."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}